Literature DB >> 8690067

Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol).

D Kirpotin1, K Hong, N Mullah, D Papahadjopoulos, S Zalipsky.   

Abstract

Plasma-stable liposomes (100 nm) were prepared from dioleoylphosphatidylethanolamine (DOPE) and 3-6 mol% of a new disulfide-linked poly(ethylene glycol)-phospholipid conjugate (mPEG-DTP-DSPE). In contrast to similar preparations containing non-cleavable PEG-phospholipid conjugate, thiolytic cleavage of the grafted polymer chains facilitated rapid and complete release of the liposome contents. Furthermore, the detachment of PEG from DOPE liposomes resulted in liposomal fusion. Finally, while formulation of pH-sensitive DOPE/cholesterol hemisuccinate liposomes with mPEG-DTP-DSPE abolished the pH sensitivity, cleavage of the PEG chains completely restored this property. These are the first examples of new useful properties of liposomes grafted with cleavable polymer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690067     DOI: 10.1016/0014-5793(96)00521-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

1.  Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism.

Authors:  Wenchao Sun; Pamela B Davis
Journal:  J Control Release       Date:  2010-05-12       Impact factor: 9.776

Review 2.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Authors:  Mary Caldorera-Moore; Nathalie Guimard; Li Shi; Krishnendu Roy
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 3.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

Review 4.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

5.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

6.  Redox-triggered contents release from liposomes.

Authors:  Winston Ong; Yuming Yang; Angela C Cruciano; Robin L McCarley
Journal:  J Am Chem Soc       Date:  2008-10-08       Impact factor: 15.419

7.  Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.

Authors:  Xuelei Yin; Yingying Chi; Chuanyou Guo; Shuaishuai Feng; Jinhu Liu; Kaoxiang Sun; Zimei Wu
Journal:  Pharm Res       Date:  2017-07-19       Impact factor: 4.200

8.  Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics.

Authors:  Junhwa Shin; Pochi Shum; Jessica Grey; Shin-ichi Fujiwara; Guarov S Malhotra; Andres González-Bonet; Seok-Hee Hyun; Elaine Moase; Theresa M Allen; David H Thompson
Journal:  Mol Pharm       Date:  2012-10-03       Impact factor: 4.939

9.  Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate.

Authors:  Jeremy A Boomer; Marquita M Qualls; H Dorota Inerowicz; Robert H Haynes; V Srilakshmi Patri; Jong-Mok Kim; David H Thompson
Journal:  Bioconjug Chem       Date:  2009-01       Impact factor: 4.774

Review 10.  Liposomal drug formulations. Rationale for development and what we can expect for the future.

Authors:  T M Allen
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.